This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marx, A. Articles by Muller-Hermelink, H. K. Search for Related Content PubMed PubMed Citation Articles by Marx, A. Articles by Muller-Hermelink, H. K.

American Journal of Pathology, Vol 148, 1839-1850, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis

A Marx, A Wilisch, A Schultz, A Greiner, B Magi, V Pallini, B Schalke, K Toyka, W Nix, T Kirchner and HK Muller-Hermelink
Institute of Pathology, University of Wurzburg, Germany.

Autoantibodies against both striated muscle proteins, particularly titin, and the acetylcholine receptor are a hallmark of thymoma- associated myasthenia gravis. However, the stimulus for these responses remains enigmatic as whole titin is not detectable in these tumors. This study reports that in thymomas with cortical differentiation many of the neoplastic epithelial cells expressed low and medium molecular weight neurofilaments detected with several antibodies (on selections and blots) and at the RNA level (by reverse transcriptase polymerase chain reaction). Moreover, higher molecular weight forms sharing at least one epitope with titin were detectable slightly less frequently, as were the more strongly phosphorylated epitopes. In stark contrast, in medullary and mixed thymomas, and especially in the normal thymus, immunoreactivity with anti-neurofilament antibodies was rare. This aberrant overexpression of a titin epitope by epithelial cells with antigen-presenting phenotype in an inappropriate cortical microenvironment suggests that they might autosensitize maturing T cells there and so initiate anti-titin autoimmunity in these patients.

This article has been cited by other articles:

				A. MARX, H. K. MULLER-HERMELINK, and P. STROBEL The Role of Thymomas in the Development of Myasthenia Gravis Ann. N.Y. Acad. Sci., September 1, 2003; 998(1): 223 - 236. [Abstract] [Full Text] [PDF]

				R Voltz, W Albrich, R Hohlfeld, D Nagel, M Wick, T Kirchner, N Sommer, I Illa, H Kaminski, and F Schumm Anti-titin antibodies are not associated with a specific thymoma histology J. Neurol. Neurosurg. Psychiatry, February 1, 2003; 74(2): 282 - 282. [Full Text]

				A. Mygland, A. Vincent, J. Newsom-Davis, H. Kaminski, F. Zorzato, M. Agius, N. E. Gilhus, and J. A. Aarli Autoantibodies in Thymoma-Associated Myasthenia Gravis With Myositis or Neuromyotonia Arch Neurol, April 1, 2000; 57(4): 527 - 531. [Abstract] [Full Text] [PDF]

				D. BEESON, A. P. BOND, L. CORLETT, S. J. CURNOW, M. E. HILL, L. W. JACOBSON, C. MACLENNAN, A. MEAGER, A-M. MOODY, P. MOSS, et al. Thymus, Thymoma, and Specific T Cells in Myasthenia Gravis Ann. N.Y. Acad. Sci., May 13, 1998; 841(1): 371 - 387. [Full Text]

				Y. LIYANAGE, M. TEO, C. MacLENNAN, A. BUCKEL, D. BEESON, N. WILLCOX, J. NEWSOM-DAVIS, and A. VINCENT Expression of Muscle Proteins in Thymomas of Patients with Myasthenia Gravis Ann. N.Y. Acad. Sci., May 13, 1998; 841(1): 411 - 413. [Full Text]

				J. A. AARLI, G. O. SKEIE, A. MYGLAND, and N. E. GILHUS Muscle Striation Antibodies in Myasthenia Gravis: Diagnostic and Functional Significance Ann. N.Y. Acad. Sci., May 13, 1998; 841(1): 505 - 515. [Full Text]

				C. Machado, C. E. Sunkel, and D. J. Andrew Human Autoantibodies Reveal Titin as a Chromosomal Protein J. Cell Biol., April 20, 1998; 141(2): 321 - 333. [Abstract] [Full Text] [PDF]